COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,019 Articles (22,627 medRxiv, 8,392 bioRxiv)

Most recent first Previous |  Page 2613: Articles 26121-26130  | Next

Mortality Analysis of COVID-19 Confirmed cases in Pakistan
Chaudhry, A., Ikram, A., Baig, M. A., Salman, M., Ghafoor, T., Hussain, Z., Khan, M. A., Ansari, J. A., Syed, A., Javed, W., Larik, E., Wattoo, M. M., Masood, N., Baig, z. I., Akram, K.
10.1101/2020.06.07.20121939 — Posted: 2020-06-09
An Inexpensive RT-PCR Endpoint Diagnostic Assay for SARS-CoV-2 Using Nested PCR: Direct Assessment of Detection Efficiency of RT-qPCR Tests and Suitability for Surveillance
Davda, J. N., Frank, K., Prakash, S., Purohit, G., Vijayashankar, D. P., Vedagiri, D., Tallapaka, K. B., Harshan, K. H., Siva, A. B., Mishra, R. K., Dhawan, J., Siddiqi, I.
10.1101/2020.06.08.139477 — Posted: 2020-06-09
Coronavirus testing indicates transmission risk increases along wildlife supply chains for human consumption in Viet Nam, 2013-2014
Huong, N. Q., Nga, N. T. T., Long, N. V., Luu, B. D., Latinne, A., Pruvot, M., Phuong, N. T., Quang, L. T. V., Hung, V. V., Lan, N. T., Hoa, N. T., Minh, P. Q., Diep, N. T., Tung, N., Ky, V. D., Roberton, S. I., Thuy, H. B., Long, N. V., Gilbert, M., Wicker, L., Mazet, J. A. K., Johnson, C. K., Goldstein, T., Tremeau-Bravard, A., Ontiveros, V., Joly, D. O., Walzer, C., Fine, A. E., Olson, S. H.
10.1101/2020.06.05.098590 — Posted: 2020-06-09
Rapid whole genome sequence typing reveals multiple waves of SARS-CoV-2 spread
Moustafa, A. M., Planet, P.
10.1101/2020.06.08.139055 — Posted: 2020-06-09
Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide
Isabel, S., Grana-Miraglia, L., Gutierrez, J. M., Bundalovic-Torma, C., Groves, H. E., Isabel, M. R., Eshaghi, A., Patel, S. N., Gubbay, J. B., Poutanen, T., Guttman, D. S., Poutanen, S. M.
10.1101/2020.06.08.140459 — Posted: 2020-06-08
Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression
Wu, C., Ye, D., Mullick, A. E., Li, Z., Daugherty, A., Lu, H. S.
10.1101/2020.06.08.137331 — Posted: 2020-06-08
SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission
Harilal, D., Ramaswamy, S., Loney, T., Varghese, R., Deesi, Z., Nowotny, N., Alsheikh-Ali, A., Abou Tayoun, A.
10.1101/2020.06.06.138339 — Posted: 2020-06-08 Discussion: Onsite
Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike
Prevost, J., Gasser, R., Beaudoin-Bussieres, G., Richard, J., Duerr, R., Laumaea, A., Anand, S. P., Goyette, G., Ding, S., Medjahed, H., Lewin, A., Perreault, J., Tremblay, T., Gendron-Lepage, G., Gauthier, N., Carrier, M., Marcoux, D., Piche, A., Lavoie, M., Benoit, A., Loungnarath, V., Brochu, G., Desforges, M., Talbot, P. J., Gould Maule, G. T., Cote, M., Therrien, C., Serhir, B., Bazin, R., Roger, M., Finzi, A.
10.1101/2020.06.08.140244 — Posted: 2020-06-08
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
Tandon, R., Sharp, J. S., Zhang, F., Pomin, V. H., Ashpole, N. M., Mitra, D., Jin, W., Liu, H., Sharma, P., Linhardt, R. J.
10.1101/2020.06.08.140236 — Posted: 2020-06-08
SARS-CoV-2-specific T cells exhibit unique features characterized by robust helper function, lack of terminal differentiation, and high proliferative potential
Neidleman, J., Luo, X., Frouard, J., Xie, G., Gurjot, G., Stein, E. S., McGregor, M., Ma, T., George, A., Kosters, A., Greene, W. C., Vasquez, J., Ghosn, E., Lee, S., Roan, N. R.
10.1101/2020.06.08.138826 — Posted: 2020-06-08 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).